Cargando…

Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn’s Disease: A Cross-Sectional Multicentric Latin American Study

Despite some variability in ideal serum Adalimumab (ADA) concentrations, there is increasing evidence that higher concentrations of anti-TNF-α agents can be associated with sustained efficacy, and low or undetectable levels may lead to loss of response. This study aims to correlate serum ADA concent...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Souza, Letícia Rodrigues, Magro, Daniela Oliveira, Teixeira, Fábio Vieira, Parra, Rogério Serafim, Miranda, Eron Fábio, Féres, Omar, Saad-Hossne, Rogério, Soares Prates Herrerias, Giedre, Nisihara, Renato Mitsunori, Coy, Claudio Saddy Rodrigues, Sassaki, Ligia Yukie, Kotze, Paulo Gustavo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967155/ https://www.ncbi.nlm.nih.gov/pubmed/36839908 http://dx.doi.org/10.3390/pharmaceutics15020586

Ejemplares similares

Quality of care in patients with inflammatory bowel disease from a public health center in Brazil
por: Takamune, Debora Mayumi, et al.
Publicado: (2022)

Hidradenitis Suppurativa as a Paradoxical Side Effect to the Use of Adalimumab in Patients with Crohn’s Disease?
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2020)

Clinical and Psychological Factors Associated with Addiction and Compensatory Use of Facebook Among Patients with Inflammatory Bowel Disease: A Cross-Sectional Study
por: Cury, Giovana Signorelli Astolfi, et al.
Publicado: (2022)

Management of inflammatory bowel disease and serum level of infliximab in newborn exposed to anti-TNF therapy during pregnancy: Case report and literature review
por: de Aragão, Maria Cecília, et al.
Publicado: (2021)

Inflammatory bowel disease epidemiology in São Paulo State, Brazil
por: Gasparini, Rodrigo Galhardi, et al.
Publicado: (2018)

Pulmonary Tuberculosis After Therapy with Anti-Tumor Necrosis Factor (TNF) for Crohn Disease: A Case Report
por: da Silva, Douglas Inomata Cardoso, et al.
Publicado: (2021)

Non-Hodgkin's Lymphoma: An Important Differential Diagnosis in Inflammatory Bowel Disease
por: Saad-Hossne, Rogerio, et al.
Publicado: (2018)

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Teixeira, Fabio Vieira, et al.
Publicado: (2019)

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease
por: Moutinho, Bruna Damásio, et al.
Publicado: (2020)

Endoscopic Postoperative Recurrence Rates in Crohn's Disease in Korea: The Beginning of a New Approach?
por: Kotze, Paulo Gustavo, et al.
Publicado: (2014)

Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
por: Imbrizi, Marcello, et al.
Publicado: (2023)

Leukocytoclastic Vasculitis as an Extraintestinal Manifestation of Crohn's Disease
por: Rocha, Thiara Barcelos, et al.
Publicado: (2021)

Anti-TNF Exposure during Pregnancy in Crohn's Disease Patients
por: Silva, Elen Farinelli de Campos, et al.
Publicado: (2018)

Intestinal complications in patients with Crohn’s disease in the Brazilian public healthcare system between 2011 and 2020
por: Sassaki, Ligia Yukie, et al.
Publicado: (2023)

Immune Thrombocytopenic Purpura as an Extraintestinal Manifestation in a Patient with Ulcerative Colitis
por: de Medeiros Dutra, Renata, et al.
Publicado: (2022)

Risk factors for ulcerative colitis-associated colorectal cancer: A retrospective cohort study
por: de Campos Silva, Elen Farinelli, et al.
Publicado: (2020)

Intestinal complications in Brazilian patients with ulcerative colitis treated with conventional therapy between 2011 and 2020
por: Martins, Adalberta Lima, et al.
Publicado: (2023)

Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of the literature
por: Grillo, Thais Gagno, et al.
Publicado: (2021)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Escherichia coli from Crohn’s disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes
por: da Silva Santos, Ana Carolina, et al.
Publicado: (2015)

Exploring the Relationship between Biologics and Postoperative Surgical Morbidity in Ulcerative Colitis: A Review
por: Quaresma, Abel Botelho, et al.
Publicado: (2021)

Long Time from Diagnosis to Surgery May Increase Postoperative Complication Rates in Elective CD Intestinal Resections: An Observational Study
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Small Intestinal Hemangioma: A Case Report
por: Beraldo, Rodrigo Fedatto, et al.
Publicado: (2021)

Rate of conversion to an open procedure: Is it really reduced in robotic colorectal surgery?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

Comparison of time until elective intestinal resection regarding previous anti-tumor necrosis factor exposure: a Brazilian study on patients with Crohn's disease
por: Kotze, Paulo Gustavo, et al.
Publicado: (2018)

Preservation of the superior rectal artery in laparoscopic colectomy for slow transit constipation: Is it really associated with better outcomes?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

Mucosa-associated but not luminal Escherichia coli is augmented in Crohn’s disease and ulcerative colitis
por: de Souza, Helton Luis, et al.
Publicado: (2012)

Correlation of serum levels of anti-tumor necrosis factor agents with perianal fistula healing in Crohn’s disease: a narrative review
por: Miranda, Eron Fabio, et al.
Publicado: (2021)

MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers
por: Quaglio, Ana Elisa Valencise, et al.
Publicado: (2021)

Spontaneous transvaginal small bowel evisceration: a case report
por: Parra, Rogério Serafim, et al.
Publicado: (2010)

Modern surgical strategies for perianal Crohn's disease
por: Zabot, Gilmara Pandolfo, et al.
Publicado: (2020)

Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil
por: Zaltman, Cyrla, et al.
Publicado: (2021)

Sexual Dysfunction in Inflammatory Bowel Disease: What the Specialist Should Know and Ask
por: Perez de Arce, Edith, et al.
Publicado: (2021)

Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
por: Cassol, Ornella Sari, et al.
Publicado: (2022)

Conventional Versus Biological Therapy for Prevention of Postoperative Endoscopic Recurrence in Patients With Crohn's Disease: an International, Multicenter, and Observational Study
por: Kotze, Paulo Gustavo, et al.
Publicado: (2015)

Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn's disease
por: Magro, Daniéla Oliveira, et al.
Publicado: (2017)

Clinical profile of Brazilian patients aged over 50 years at the diagnosis of celiac disease
por: Kotze, Lorete Maria da Silva, et al.
Publicado: (2023)

Primary sclerosing cholangitis associated with severe ulcerative colitis in a young man
por: Xavier, José Cândido Caldeira, et al.
Publicado: (2013)

Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
por: Feitosa, Marley R., et al.
Publicado: (2021)

Celiac disease in native Indians from Brazil: A clinical and epidemiological survey
por: Utiyama, Shirley Ramos da Rosa, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_btvgi52aisoa957mg2ri107lmo